The “Pharmacogenetics in Psychiatry Interest Group (PPIG)” has evolved as a sub-group with support from the Pharmacogenomic Global Research Network (PGRN) leadership. Established in March 2021, the PPIG meets every two months and aims to bring together scientists from all over the world, working in academia and industry, interested in the exciting and emerging field of Psychiatric Pharmacogenomics. 

Through our virtual meetings, we will discuss and disseminate ongoing and prospective research related to the implementation of PGx into the psychiatric clinical practice, including cost reimbursement and electronic health record opportunities. Given the diverse nature of our group, researchers have the opportunity to drive different healthcare systems and regimes, learn, adopt strategies that fit their organizations and be better prepared to act as implementers. Moreover, group members will actively engage in networking and assist early career researchers in their career planning and facilitate contacts to senior researchers in Psychiatric PGx. Educational and knowledge translation activities are organized in conjunction with PGRN and linked to larger conferences where in-person meetings are organized. The group is committed to promoting and addressing equity, diversity, and inclusion in research and clinical practice. As the group evolves, we will seek publication and funding opportunities to achieve maximum output through joint efforts. To serve our purpose, we welcome new members and volunteers from across the globe to join our meetings, especially from developing countries, and help in the organization and curation of our group efforts.

Daniel Mueller


The Psychiatry Special Interest Group is delighted to present periodic zoom seminars at our regular Psychiatry SIG meetings. 
Presentations feature leading researchers at the intersection of PGx and psychiatry and allow ample time for discussion. The details of our most recent seminar are below and new details will be posted once they become available. 

Role of polymorphic CYP2C19 and CYP2D6 enzymes in psychiatric phenotypes and psychiatric drug metabolism

Thursday, December 1, 2022, 12-2 pm EST

Presenter: Assoc. Prof. Marin Jukić, PharmD
University of Belgrade - Pharmacy school, Serbia
Karolinska Institute, Stockholm, Sweden

Dr. Marin Jukić earned an MSc degree in pharmacy at the University of Belgrade, Serbia, completed his PhD in neuroscience at Ben Gurion University, Israel, and received postdoctoral training at Karolinska Institute, Sweden. Marin is currently employed as an associate professor at the University of Belgrade and a senior researcher at Karolinska Institute. Dr. Marin Jukić research is focused on brain development, monoaminergic neurotransmission, neuropsychopharmacology, and pharmacogenetics in psychiatry.

Seminar Access
A zoom link will be sent out to all members of the Psychiatry Interest Group. If you would like to join the interest group, please reach out to

PGRN awards, seminars and meetings are open to Members Only.

Join now so you can take advantage of PGRN's seminars, research in progress sessions,
tool kits and awards.

Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.

PGRN is a 501(c)3 Non-Profit Association

Follow PGRN
on Social Media

Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Join your colleagues today and suport the work of PGRN. 
Powered by Wild Apricot Membership Software